Adani Ports, Auro Pharma, Apollo Hospitals Q2 previews: Here's what analysts say

Phillip Capital expects Adani Ports' Q2FY24 revenue to come in at Rs 6,344.3 crore, flat sequentially but up 22 per cent YoY. Ebitda may remain flat QoQ to Rs 3,783 crore, it said.

Related Keywords

Tamil Nadu ,India ,Aurobindo Pharma ,Prabhudas Lilladher ,Apollo Hospital Enterprises Ltd ,Aurobindo Pharma Ltd ,Economic Zone Ltd ,Apollo Hospital Enterprises ,Adani Ports ,Special Economic Zone Ltd ,Institutional Equities ,Apollo Hospital ,Apollo Hospitals ,Yoy Ebitda ,Adani Port ,Adani Ports And Special Economic Zone ,Dani Ports Q2 Results Preview ,Uro Pharma Q2 Results Preview ,Pollo Hospitals Q2 Results Preview ,Dani Ports Results Preview ,Uro Pharma Results Preview ,Pollo Hospitals Results Preview ,Dani Ports Q2 Preview ,Uro Pharma Q2 Preview ,Apollo Hospitals Q2 Preview ,